Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?
about
EndothelinEndothelin and the glomerulus in chronic kidney diseasePresent and future in the treatment of diabetic kidney diseaseNuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytesEndothelin receptors and their antagonistsVascular dysfunction as a target for adjuvant therapy in cerebral malariaCardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationEndothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12Endothelin and endothelin antagonists in chronic kidney disease.Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension.Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculationEndothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.Endothelin-1 and the kidney: new perspectives and recent findings.Cardiac Fibrosis: The Fibroblast AwakensEndothelin antagonists for diabetic and non-diabetic chronic kidney disease.Causes and treatment of oedema in patients with heart failure.Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Endothelin Receptor Antagonists: New Hope for Renal Protection?Endothelial dysfunction and vascular disease - a 30th anniversary update.Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia.Evidence for biased agonists and antagonists at the endothelin receptorsAssociation of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials.Macitentan: An important addition to the treatment of pulmonary arterial hypertension.Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteriesEndothelin antagonists in diabetic nephropathy: back to basics.Themed section: endothelin.
P2860
Q26767156-AF70A35A-1D41-49FE-ACCB-55B068EF76E6Q26828634-768F54EF-0433-464A-B84F-D5FDE6021B2BQ26864133-185FBE23-92FB-4FC6-A006-CF58F3CC2B99Q27015977-C631CB48-5515-49C9-8787-E1AD5683C13CQ27023208-574152BF-2ABF-4839-B023-743EAB748C36Q27025436-52EE0F4D-2476-4498-9334-4962EBC112B0Q28068468-A4EF89BA-A403-4653-8FC7-4E579AC3AEACQ28246158-FB71FF32-D8F3-496B-9610-0DC8A6A5DC4EQ34437692-E2856B1F-FEA8-491E-8C27-44D3D034180EQ34889050-D0C2A30C-F645-4F0F-8C28-77DBDC11B970Q34957350-22B84AE7-4948-4FFF-8FF5-36CEF6BCFC71Q35668241-885DBA74-9DAF-4FB9-9869-4B2342832F50Q36421114-3A2F858C-48BB-4023-897C-CC662A7A0501Q36708340-A4BA88F4-8E1A-4AA9-8E6E-7D1CE40F85B2Q37219055-6168F739-B73D-4B5B-A5BF-F3C16D531235Q38074093-B2333CEA-91B7-454E-9FDE-5B164BCF2094Q38085054-D240B903-E495-4F22-98E2-3252140A73E1Q38209811-B918F449-123E-4AFC-AB91-AF1ADE80B149Q38525983-9889749F-5B03-405C-A003-82A1536A2A53Q38680112-595D3679-0415-42C0-B543-84665AFF06F7Q38703088-2BC9009A-E1CE-499E-8198-3F4D84C3B567Q38742466-C216FD75-FF34-452A-96E8-9C801FC1191FQ39106330-D99D3E01-307E-416B-9B2B-9B3CCD0343C8Q40259209-697B6816-B511-4479-9689-60BDEC52C4ECQ41031513-FCF71699-931E-46C5-93B2-1011E0EFCCC0Q41867443-162918FE-77FD-4334-AAC9-AF74746C834CQ41974344-7E3A7339-C4F0-4CB6-BEA6-5DA6BDDA46C9Q42547440-276C105C-8BA2-43C9-ABDF-5173F6D185D8Q43247526-46FEAD71-EAF5-40C6-AEC6-1A786178BD10
P2860
Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical trials with endotheli ...... rong and where can we improve?
@en
Clinical trials with endotheli ...... rong and where can we improve?
@nl
type
label
Clinical trials with endotheli ...... rong and where can we improve?
@en
Clinical trials with endotheli ...... rong and where can we improve?
@nl
prefLabel
Clinical trials with endotheli ...... rong and where can we improve?
@en
Clinical trials with endotheli ...... rong and where can we improve?
@nl
P2093
P1433
P1476
Clinical trials with endotheli ...... rong and where can we improve?
@en
P2093
Dan Theodorescu
Donald E Kohan
Lewis J Rubin
Matthias Barton
P304
P356
10.1016/J.LFS.2012.07.034
P407
P50
P577
2012-08-06T00:00:00Z